Jan-Paul Bohn, MD, PhD

Department of Internal Medicine V, Medical University Innsbruck, Austria

N/A

Poster(s):

• 1141 - Reduced predictive value of elevated Beta-2-microglobulin plasma levels on time to first treatment in newly diagnosed CLL patients with compromised kidney function

• 1205 - Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2nd Line Improves Progression Free Survival: Long Term Follow up of the International Randomized AGMT-CLL8/a Mabtenance Trial